Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of Preeclampsia
- 1 October 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 50 (4) , 686-692
- https://doi.org/10.1161/hypertensionaha.107.092098
Abstract
Inhibitors of angiogenic factors are known to be upregulated, and their levels increase in the maternal circulation before the onset of preeclampsia. We reproduced a previously characterized model ...Keywords
This publication has 13 references indexed in Scilit:
- Placental Lactate Transporter Activity and Expression in Intrauterine Growth RestrictionReproductive Sciences, 2006
- Soluble endoglin contributes to the pathogenesis of preeclampsiaNature Medicine, 2006
- PreeclampsiaHypertension, 2005
- Managing Patients Treated with Bevacizumab Combination TherapyOncology, 2005
- B-Type Natriuretic Peptide Exerts Broad Functional Opposition to Transforming Growth Factor-β in Primary Human Cardiac FibroblastsCirculation Research, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with PreeclampsiaJournal of Clinical Endocrinology & Metabolism, 2003
- Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transferProceedings of the National Academy of Sciences, 2001
- The vascular endothelial growth factor family of polypeptidesJournal of Cellular Biochemistry, 1991